Advertisement

Die leukozytäre Antwort

  • E. Christophers
  • J.-M. Schröder
Conference paper
Part of the Der Hautarzt book series (VDGDERMATOLOGIE, volume 34)

Zusammenfassung

Die polymorphkernigen neutrophilen Leukozyten (PMN) stellen den Hauptteil der im peripheren Blut zirkulierenden Leukozyten. Ihre große Bedeutung in der Abwehr von Infekterregern wurde vor mehr als 100 Jahren erkannt. Es waren vor allem Eli Metchnikoff und Julius Cohnheim, die die Phänomene Migration, chemotaktische Wanderung und Phagozytose als erste exakt beschrieben. Die Erkenntnis, daß die Zellen Granula besitzen, die sie im Entzündungsgeschehen sezernieren, stammt von Paul Ehrlich. Diese grundlegenden Beobachtungen kennzeichnen den Beginn der Erforschung der vielfachen Funktionen der Zellen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Benveniste J, E Jouvin, E Pirotzky, B Arnoux, JM Mencia-Juerta, R Roubin, BB Vargaftig (1981) Platelet-activating factor (PAF-acether): molecular aspects of its release and pharmacological actions. Int Arch Allergy Appl Immunol 66 Suppl 1:121CrossRefGoogle Scholar
  2. 2.
    Bjork H, P Hedquist P, KE Arfors (1982) Increase in vascular permeability induced by leukotriene B4 and the role of polymorphonuclear leukocytes. Inflammation 6:189PubMedCrossRefGoogle Scholar
  3. 3.
    Chenoweth DE and TE Hugli (1980) Binding, internalization and degradation of human C5a by human neutrophils. Fed Proc 39:1049Google Scholar
  4. 4.
    Christophers E (1984) Das Spektrum entzündlicher Dermatosen. Allergologie 7:165–172Google Scholar
  5. 5.
    Colditz IG, HZ Movat (1984) Kinetics of neutrophil accumulation in acute inflammatory lesions induced by chemotaxins and chemotaxigens. J Immunol 133:2169–2173PubMedGoogle Scholar
  6. 6.
    Colditz IG and HZ Movat (1984) Desensitization of acute inflammatory lesions to chemotaxins and endotoxon. J Immunol 133:2163–2168PubMedGoogle Scholar
  7. 7.
    Fernandez HN, PM Henson, A Otani, and TE Hugli (1978) Chemotactic response to human C3a and C5a anaphylatoxins. J Immunol 120:109PubMedGoogle Scholar
  8. 8.
    Gallin JI, PG Quie (1977) Leukocyte Chemotaxis: Methods, Physiology, Clinical Implications. New York Raven PressGoogle Scholar
  9. 9.
    Hugli TE and EC Moygan (1984) Mechanisms of Leukocyte Regulation by Complement-derived Factors. In: Regulation of Leukocyte Function. Ed by Snyderman R, Plenum Press, New York 109–153Google Scholar
  10. 10.
    Ick D, JM Schröder, E Christophers Untersuchung von Granulozytenfunktionen bei erscheinungsfreien Psoriatikern. Vortrag auf der 34. Tagung der Deutschen Dermatologischen Gesellschaft, Zürich 20.-24.3.1985Google Scholar
  11. 11.
    Issekutz AC, M Ripley, JR Jackson (1983) Role of neutrophils in the deposition of platelets during acute inflammation. Lab Invest 49:716PubMedGoogle Scholar
  12. 12.
    Issekutz AC (1984) Role of polymorphonuclear leukocytes in the vascular responses in acute inflammatory. Lab Invest 30:605–607Google Scholar
  13. 13.
    Kawohl G, B Szperalski, JM Schröder, E Christophers (1980) Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serum. Brit J Dermatol 103:527–533CrossRefGoogle Scholar
  14. 14.
    Lundberg C, L Lebel, C Bengt (1984) Inflammatory reaction in an experimental model of open wounds in the rat: the role of polymorphonuclear leukocytes. Lab Invest 50:726PubMedGoogle Scholar
  15. 15.
    Luger TA, JA Charon, M Colot, M Micksche, and JJ Oppenheim (1983) Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells. J Immunol 131:816PubMedGoogle Scholar
  16. 16.
    Palmblad J, CL Malmsten, AM Uden, O Radmark, L Engstedt, B Samuelsson (1981) Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence. Blood 58:658PubMedGoogle Scholar
  17. 17.
    Preissner WC, JM Schröder, E Christophers (1983) Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation. Brit J Dermatol 109:1–8CrossRefGoogle Scholar
  18. 18.
    Schröder JM, E Christophers (in press) Transient Absence of C5a-specific Neutrophil Function in Inflammatory Disorders of the Skin. J Invest DermatolGoogle Scholar
  19. 19.
    Shaw JO, RN Pinckard, KS Ferrigni, LM McManus, DJ Hanahan (1981) Activation of human neutrophils with l-o-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor). J Immunol 127:1250PubMedGoogle Scholar
  20. 20.
    Sauder DL, NL Mounessa, SI Katz, CA Dinarello, JI Gallin (1984) Chemotactic cytokines: the role of leukocyte pyrogen and epidermal cell derived thymocyte-activating factor in neutrophil chemotaxis. J Immunol 132:828PubMedGoogle Scholar
  21. 21.
    Valone FH, EJ Goetzel (1983) Specific binding by human polymorphonuclear leucocytes of the immunological mediator 1-o-hexadecyl/octadecyl-2acetyl-sn-glycero-3-phosphorylcholine. Immunol 48:141Google Scholar
  22. 22.
    Williams TJ, MJ Peck (1977) Role of prostaglandinmediated vasodilatation in inflammation: histamineindependent action of rabbit C5a. Nature 270:530PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • E. Christophers
    • 1
  • J.-M. Schröder
  1. 1.Dermatologie und VenerologieKlinikum der Universität KielKielDeutschland

Personalised recommendations